C4 Therapeutics Inc. (CCCC)
3.18
+0.01 (0.32%)
Upcoming Events
Latest Headlines
Insmed adds two independent directors with biopharma backgrounds
October 20, 2026 7:00 AM - StreetInsider
Insmed Appoints Two New Directors to Its Board
October 20, 2026 7:00 AM - PR NewsWire
JPMorgan Starts C4 Therapeutics (CCCC) at Overweight
October 9, 2026 3:22 AM - StreetInsider
Form 4 C4 Therapeutics, Inc. For: Oct 01 Filed by: Anderson Kenneth Carl
October 2, 2026 4:44 PM - SEC Filing
Form 4 C4 Therapeutics, Inc. For: Oct 01 Filed by: GROGAN DONNA ROY
October 2, 2026 4:44 PM - SEC Filing
Form 8-K C4 Therapeutics, Inc. For: Sep 25
September 25, 2026 7:04 AM - SEC Filing
C4 Therapeutics shares cemsidomide biomarker data at myeloma meeting
September 25, 2026 7:00 AM - StreetInsider
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd I
September 25, 2026 7:00 AM - StreetInsider
Form 4 C4 Therapeutics, Inc. For: Sep 18 Filed by: Adams Kendra
September 21, 2026 4:25 PM - SEC Filing
C4 Therapeutics to present cemsidomide biomarker data at myeloma meeting
September 3, 2026 7:00 AM - StreetInsider
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd I
September 3, 2026 7:00 AM - StreetInsider
Form 144 C4 Therapeutics, Inc. Filed by: Mossler Mark
August 14, 2026 7:14 PM - SEC Filing
Form 144 C4 Therapeutics, Inc. Filed by: Geldmacher Jay L
August 14, 2026 6:56 PM - SEC Filing
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
August 14, 2026 4:48 PM - SEC Filing
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: Lynx1 Capital Management LP
August 14, 2026 4:40 PM - SEC Filing
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: Squadron Capital Management LLC
August 14, 2026 12:54 PM - SEC Filing
Form 144 C4 Therapeutics, Inc. Filed by: Mossler Mark
August 13, 2026 4:19 PM - SEC Filing
Form 144 C4 Therapeutics, Inc. Filed by: Mossler Mark
August 12, 2026 5:31 PM - SEC Filing
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: MORGAN STANLEY
August 12, 2026 4:42 PM - SEC Filing
Form 10-Q C4 Therapeutics, Inc. For: Jun 30
August 11, 2026 7:30 AM - SEC Filing
C4 Therapeutics, Inc. (CCCC) Tops Q2 EPS by 3c
August 11, 2026 7:23 AM - StreetInsider
Form 8-K C4 Therapeutics, Inc. For: Aug 11
August 11, 2026 7:14 AM - SEC Filing
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 11, 2026 7:00 AM - StreetInsider
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 10, 2026 4:01 PM - StreetInsider
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Full Article List
